LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | Enzastaurin | 0.04 | uM | LJP5 | 3 | D18 | 72 | hr | 1235 | 4692 | 4929 | 0.9519 | 0.9512 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 1 | D17 | 72 | hr | 1235 | 4911 | 4474 | 1.0975 | 1.1028 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 2 | D17 | 72 | hr | 1235 | 4653 | 4578 | 1.0163 | 1.0171 |
MDA-MB-231 | Enzastaurin | 0.12 | uM | LJP5 | 3 | D17 | 72 | hr | 1235 | 5071 | 4929 | 1.0287 | 1.0286 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 1 | D16 | 72 | hr | 1235 | 4682 | 4474 | 1.0463 | 1.0494 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 2 | D16 | 72 | hr | 1235 | 5020 | 4578 | 1.0964 | 1.0998 |
MDA-MB-231 | Enzastaurin | 0.37 | uM | LJP5 | 3 | D16 | 72 | hr | 1235 | 4785 | 4929 | 0.9707 | 0.9705 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 1 | D15 | 72 | hr | 1235 | 4859 | 4474 | 1.0859 | 1.0908 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 2 | D15 | 72 | hr | 1235 | 4923 | 4578 | 1.0752 | 1.0783 |
MDA-MB-231 | Enzastaurin | 1.11 | uM | LJP5 | 3 | D15 | 72 | hr | 1235 | 4869 | 4929 | 0.9878 | 0.9877 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 1 | D14 | 72 | hr | 1235 | 4625 | 4474 | 1.0336 | 1.0359 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 2 | D14 | 72 | hr | 1235 | 4850 | 4578 | 1.0593 | 1.0619 |
MDA-MB-231 | Enzastaurin | 3.33 | uM | LJP5 | 3 | D14 | 72 | hr | 1235 | 4952 | 4929 | 1.0046 | 1.0046 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 1 | D13 | 72 | hr | 1235 | 4842 | 4474 | 1.0821 | 1.0868 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 2 | D13 | 72 | hr | 1235 | 5273 | 4578 | 1.1517 | 1.1552 |
MDA-MB-231 | Enzastaurin | 10 | uM | LJP5 | 3 | D13 | 72 | hr | 1235 | 5417 | 4929 | 1.0989 | 1.0968 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 1 | E18 | 72 | hr | 1235 | 2774 | 4355 | 0.6368 | 0.5603 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 2 | E18 | 72 | hr | 1235 | 2740 | 4277 | 0.6406 | 0.5597 |
MDA-MB-231 | Palbociclib | 0.04 | uM | LJP6 | 3 | E18 | 72 | hr | 1235 | 2998 | 4583 | 0.6541 | 0.5978 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 1 | E17 | 72 | hr | 1235 | 2435 | 4355 | 0.5590 | 0.4523 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 2 | E17 | 72 | hr | 1235 | 2555 | 4277 | 0.5973 | 0.5000 |
MDA-MB-231 | Palbociclib | 0.12 | uM | LJP6 | 3 | E17 | 72 | hr | 1235 | 2722 | 4583 | 0.5939 | 0.5183 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 1 | E16 | 72 | hr | 1235 | 2114 | 4355 | 0.4853 | 0.3436 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 2 | E16 | 72 | hr | 1235 | 2371 | 4277 | 0.5543 | 0.4387 |
MDA-MB-231 | Palbociclib | 0.37 | uM | LJP6 | 3 | E16 | 72 | hr | 1235 | 2333 | 4583 | 0.5090 | 0.3994 |